Y-mAbs Therapeutics
Steve Do has a rich and diverse work experience. Steve is currently serving as a Strategic Account Manager - West at Y-mAbs Therapeutics, Inc., where they are leading the launch of Danyelza for R/R Neuroblastoma in several states. Steve is responsible for building awareness and educating key accounts, collaborating with key stakeholders, and coordinating internal partnerships.
Prior to their current role, Steve worked at Puma Biotechnology, Inc. as a Senior Clinical Specialist and Area Training Manager Hybrid. Steve also worked at Medivation as a Senior Clinical Oncology Specialist and at Onyx Pharmaceuticals, Inc. as a Senior Clinical Oncology Specialist.
Steve's earlier experiences include working at Eli Lilly and Company as an Executive Oncology Sales Specialist and a Diabetes Sales Representative. Steve also worked as a Physician Recruiter at Pacific Companies.
Steve Do attended UC Irvine from 1997 to 2002, where they earned a Bachelor of Arts (B.A.) degree in Economics.
This person is not in any offices
Y-mAbs Therapeutics
Y-mAbs is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer.